Efficacy and safety of ciclesonide administered with or without different spacers in patients with asthma (12 to 75 y) (BY9010/M1-145)
Study identifier:BY9010/M1-145
ClinicalTrials.gov identifier:NCT00163436
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Comparison of the Efficacy and Safety of 160 mcg Ciclesonide Administered Once Daily in the Evening with or without Different Spacer Types in Patients with Asthma
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
No
Study drug
Ciclesonide
Sex
All
Actual Enrollment
450
Study type
Interventional
Age
12 Years - 75 Years
Date
Study Start Date: 01 Sept 2005
Primary Completion Date: 01 Jan 2006
Study Completion Date: 01 Jan 2006
Study design
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Oct 2016 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca AstraZeneca
AstraZeneca
